Sotera Health (SHC) Is Getting Attention Again, What Is Behind It?

Simply Wall St.08-10 12:44

Sotera Health (SHC) is back in focus after its second quarter 2026 earnings, with the company reporting higher revenue of US$321.38 million and net income of US$53.64 million compared with the prior ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2658860766?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","is_english":true,"pubTime":"2026-08-10 12:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2658860766","market":"us","top_or_hot":-1,"title":"Sotera Health (SHC) Is Getting Attention Again, What Is Behind It?","media":"Simply Wall St.","content":"<div>\n<p>Sotera Health (SHC) is back in focus after its second quarter 2026 earnings, with the company reporting higher revenue of US$321.38 million and net income of US$53.64 million compared with the prior ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-shc/sotera-health/news/sotera-health-shc-is-getting-attention-again-what-is-behind\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sotera Health (SHC) Is Getting Attention Again, What Is Behind It?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSotera Health (SHC) Is Getting Attention Again, What Is Behind It?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-10 12:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-shc/sotera-health/news/sotera-health-shc-is-getting-attention-again-what-is-behind><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Sotera Health (SHC) is back in focus after its second quarter 2026 earnings, with the company reporting higher revenue of US$321.38 million and net income of US$53.64 million compared with the prior ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-shc/sotera-health/news/sotera-health-shc-is-getting-attention-again-what-is-behind\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FEBU","symbol_name":"AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-shc/sotera-health/news/sotera-health-shc-is-getting-attention-again-what-is-behind","article_id":"2658860766","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-shc/sotera-health/news/sotera-health-shc-is-getting-attention-again-what-is-behind","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2658860766","pubTimestamp":1786337079,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Sotera Health (SHC) is back in focus after its second quarter 2026 earnings, with the company reporting higher revenue of US$321.38 million and net income of US$53.64 million compared with the prior year.\nSee our latest analysis for Sotera Health.\nThe earnings release appears to be the main catalyst behind Sotera Health’s recent momentum, with the stock showing a 22.23% 90 day share price return and a 35.00% one year total shareholder return, despite a weaker five year total shareholder...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"FEBU":"AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF","DECU":"AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF","BK4588":"碎股","BK4585":"ETF&股票定投概念","PMDE":"PGIM S&P 500 Max Buffer ETF - December","RGLO":"Global Equity Active ETF","VOTE":"TCW Transform 500 ETF","BK4121":"生命科学工具和服务","JOYT":"JPMorgan Equity and Options Total Return ETF","GXDW":"Global X Dorsey Wright Thematic ETF","SHC":"Sotera Health Company","VGFPF":"Vanguard Funds PLC"},"translate_title":"索特拉健康（SHC）再次受到关注，背后是什么？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JOYT":0.61,"FEBU":0.61,"VOTE":0.61,"PMDE":0.61,"SHC":1.5,"VGFPF":0.61,"GXDW":0.61,"RGLO":0.61,"DECU":0.61},"content_text":"Sotera Health (SHC) is back in focus after its second quarter 2026 earnings, with the company reporting higher revenue of US$321.38 million and net income of US$53.64 million compared with the prior year. See our latest analysis for Sotera Health. The earnings release appears to be the main catalyst behind Sotera Health’s recent momentum, with the stock showing a 22.23% 90 day share price return and a 35.00% one year total shareholder return, despite a weaker five year total shareholder return of 22.70%. If Sotera Health’s earnings story has you watching the sector more closely, it could be a good moment to broaden your search and check out 43 healthcare AI stocks. Sotera Health’s sharp move after earnings creates a clear gap between the current US$18.86 share price and various fair value estimates. The next step is to identify where that range clusters and how wide the buffer appears. AdvertisementMost Popular Narrative: 6.7% Undervalued The most followed narrative places Sotera Health’s fair value at $20.22 per share, slightly above the recent $18.86 close, which frames the current optimism around the stock in a more structured way.  The analysts have a consensus price target of $20.22 for Sotera Health based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $24.0, and the most bearish reporting a price target of just $16.0.  Read the complete narrative. Read the complete narrative. Want to understand why the story points to a higher valuation for Sotera Health? The core of the narrative rests on the interaction of quicker profit growth, firmer margins, and a valuation multiple that assumes those earnings arrive on schedule. The exact mix of these assumptions is where the real insight sits. Result: Fair Value of $20.22 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, Sotera Health still faces meaningful risks, including higher ethylene oxide compliance and litigation costs, as well as rising competition from alternative sterilization technologies that could pressure future assumptions. Find out about the key risks to this Sotera Health narrative. Another View on Sotera Health’s Valuation The earlier section focused on analyst fair value targets for Sotera Health. Our DCF model suggests a different perspective, with an estimated future cash flow value of $28.53 compared with the current $18.86 share price. On this basis, the stock appears undervalued when assessed using cash flows. Which set of assumptions do you find more reasonable? Look into how the SWS DCF model arrives at its fair value. SHC Discounted Cash Flow as at Aug 2026Next Steps With sentiment split between risks and rewards for Sotera Health, it makes sense to move fast and test the assumptions against your own view using the 4 key rewards and 1 important warning sign. Looking for more Sotera Health style investment ideas? If Sotera Health has sharpened your focus, do not stop with a single stock. Broaden your watchlist now and give yourself more options before the next move.  Spot potential bargains early by scanning screener containing 21 high quality undiscovered gems that pair solid fundamentals with relatively low market attention. Strengthen your defense by reviewing 83 resilient stocks with low risk scores that aim to keep volatility and risk scores in check. Target resilient financial footing by focusing on solid balance sheet and fundamentals stocks screener (48 results) that emphasize cash strength and manageable debt.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2658860766","isCrawlerRequest":true}